Kellie Combs, Ropes & Gray life sciences partner, analyzes three documents released by the FDA outlining the agency’s current thinking regarding drug and device manufacturers’ communication of information not contained in FDA-approved labeling.
Trending Legal Topics Similar Videos
UK corporate offence of failure to prevent tax evasion
Andrew Howard, Ropes & Gray tax partner, discusses the UK’s new corporate criminal offence of failure to prevent tax evasion, which goes into effect in September 2017.
Value-based health care: provider integration
John Chesley, Ropes & Gray health care partner, addresses developments for providers to consider as they integrate and move towards value-based health care models.
Cloud computing security
Jim DeGraw, Ropes & Gray technology partner, addresses cloud computing security issues that companies should be aware of as they consider moving data to the cloud.
Changing values of IP and data in deals
Ed Black, co-head of Ropes & Gray’s IP transactions and technology, media & telecommunications practice groups, discusses changing values of IP and data in M&A transactions.
FTC's merger remedies study
Jonathan Klarfeld, Ropes & Gray antitrust partner, discusses key takeaways and likely impacts of the Federal Trade Commission's recent divestiture study.
Department of Labor's Fiduciary Rule
David Tittsworth, Ropes & Gray investment management counsel, analyzes the possible fate of the Department of Labor’s Fiduciary Rule.